The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those on a newly initiated oral antidepressant plus placebo
Spravato Treatment in Memorial, Houston TX: FDA-Approved Relief for Treatment-Resistant Depression
Find the best Spravato treatment clinic serving Memorial, Houston TX at Catalyst Health & Wellness — a REMS-certified provider of the only FDA-approved nasal spray for treatment-resistant depression. Led by Dr. Ho, board-certified anesthesiologist and former pediatrician. Three Houston locations open Monday–Sunday, 5am–9pm.
Restore Hope with Spravato Treatment Memorial
Memorial is where Houston’s quiet wealth lives — forested neighborhoods tucked between the Energy Corridor and Buffalo Bayou, mid-century modern architecture shaded by mature trees, the Memorial Villages with their nationally accredited schools and independent village governments, and a stretch of I-10 that connects residents to the best institutions the city offers. It’s a community with deep roots and high expectations. People here have built lives that look, from the outside, exactly as they intended.
But treatment-resistant depression doesn’t respect that exterior. It settles into the most carefully constructed lives just as readily as anywhere else, and when antidepressants have failed to lift it — not once, but repeatedly — the gap between the life you’re living and the life you’re capable of can feel quietly insurmountable. If two or more medications haven’t produced the sustained relief you needed, the problem isn’t your resilience. It’s your biology, and more specifically, it’s the mismatch between your brain’s neurochemical needs and the mechanism of every treatment you’ve been offered. At Catalyst Health & Wellness, we serve Memorial residents — and patients from the Energy Corridor, Spring Branch, Hedwig Village, Bunker Hill Village, River Oaks, and west central Houston — as a fully REMS-certified Spravato provider. Washington University in St. Louis describes esketamine as a treatment that, through its action on the glutamate NMDA receptor, “activates brain pathways that promote brain cell growth, the connection between these cells, and neuroplasticity” — a neurobiological process no prior antidepressant class initiates. With Dr. Ho’s clinical precision, thorough insurance support, and extended hours, Catalyst puts that pathway within reach for Memorial patients who are ready to take it.
What is Spravato Therapy?
Spravato (esketamine) earned FDA breakthrough therapy designation before receiving full approval in 2019 — the first antidepressant to introduce a new mechanism of action in over three decades. The FDA expanded that approval in 2020 to adults with major depressive disorder and active suicidal ideation. In January 2025, the FDA granted Spravato approval as a standalone monotherapy for TRD — making it the first and only medication ever cleared to treat treatment-resistant depression without requiring a concurrent oral antidepressant.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Memorial
Spravato holds FDA approval for two specific, well-documented clinical indications — every qualifying Memorial patient receives a treatment with a rigorously established evidence record. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every phase of the Spravato process at Catalyst has been built to reduce friction and make treatment genuinely accessible to Memorial patients with demanding lives. Here's what to expect from first call through long-term maintenance.
Step 1: Free Phone Consultation
Your first call is free and commits you to nothing. A clinical team member will discuss your depression history, medication background, and what daily life looks like now. You’ll receive an honest assessment of whether Spravato makes sense for your situation — and a direct answer if it doesn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles it entirely: benefit verification, documentation preparation, prior auth submission, and insurer follow-up until approval is secured. You focus on the decision; we manage the administrative burden.
Step 3: Before Your First Visit
Before your appointment, we’ll walk through everything: dietary guidelines, what to bring, how to arrange transportation, and any timing notes for current medications. Nothing about your first session will be unclear before you arrive.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days isn’t permitted. Come comfortable and ready to rest. That’s all the preparation required.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room — reclinable chair, soft adjustable lighting, warm blankets, noise-cancelling headphones available. Spravato is self-administered as a nasal spray under direct clinical supervision. Dr. Ho’s team monitors your vital signs, blood pressure, and overall response throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour monitoring window.
Step 6: Recovery & Aftercare
After monitoring concludes, you’ll leave with your driver. Driving should wait until the morning after a full night’s sleep. Our team follows up between sessions to track your response and adjust anything before your next visit.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based on how you’re actually responding. Your progress shapes the schedule.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s FDA approval rests on a robust clinical evidence base: two pivotal phase 3 randomized controlled trials, a 2025 monotherapy approval study, and nearly six years of post-approval real-world data reviewed by regulatory bodies in more than 77 countries.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients receiving Spravato were 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours of the first dose — reflecting the neuroplasticity cascade Washington University’s program describes: glutamate NMDA receptor blockade activating pathways that promote brain cell growth, synaptic connection, and reorganization. This is not a monoamine effect — it’s a structural process that begins within hours.
The SUSTAIN-1 trial, published in JAMA Psychiatry, established the durability of those gains. Patients who achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued showed significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003). Maintenance treatment is a genuine clinical investment in the stability patients achieve during induction.
Key research findings:
- Spravato activates pathways that promote brain cell growth, synaptic connection, and neuroplasticity in the prefrontal cortex — rebuilding the architecture that chronic depression has progressively eroded
- The ASPIRE I and II trials confirmed statistically significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the first FDA-approved rapid pharmacological option for that clinical population
- Yale University researchers participating in the VA’s national comparative effectiveness study describe esketamine as “the only currently FDA-approved approach that holds the promise of being a breakthrough” for treatment-resistant depression
- The January 2025 FDA monotherapy approval is the most recent milestone in an evidence base spanning more than a decade of research and real-world use across over 140,000 patients worldwide
Why Choose Catalyst Health & Wellness for Spravato Treatment in Memorial
01
REMS-Certified Provider
The FDA requires all Spravato treatments to occur in a certified healthcare setting under its Risk Evaluation and Mitigation Strategy (REMS) program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations. Every session Memorial patients receive meets every federal safety standard, without exception.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho’s background is precisely what Spravato treatment demands. His board certification in anesthesiology means deep expertise in esketamine pharmacology, clinical dosing, and the physician-level monitoring that administering an NMDA receptor antagonist requires. His background as a former pediatrician defines the culture of the entire clinic — patient-centered, genuinely attentive, and focused on how treatment feels from your perspective rather than just how it tracks on a metric. Memorial residents who hold every institution they rely on to a high standard will find that standard met.
03
Insurance Navigation Support
Spravato stands apart from most innovative mental health treatments because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always required, and navigating that system while managing depression is a burden patients shouldn’t carry alone. Our team handles it entirely: benefit verification, prior auth submission, insurer communication, and appeals when needed.
04
Whole-Person Approach
From the first call, we engage with you as a complete person — your full treatment history, your current situation, your goals, and what you’re trying to recover. Treatment plans are built around that full picture and updated as your response evolves. What this means for you:
- Plans personalized to your specific history and present circumstances
- Ongoing adjustments based on real response data, not a preset protocol
- Coordination with your existing psychiatrist or prescribing physician
- Long-term engagement extending well beyond the initial induction series
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. For Memorial residents managing demanding professional careers in the energy sector, healthcare, or financial services — and the time demands of living in one of Houston’s premier neighborhoods — fitting a standard weekday clinical window into the schedule is often genuinely impossible. Our 5am to 9pm hours, seven days a week at all three Houston locations, solve that problem. Pre-dawn appointments, evening sessions, weekend treatment — all available. Our Heights location is directly accessible from the Memorial area.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone.
Getting Started with Spravato Treatment in Memorial
Memorial residents are accustomed to choosing the best option in every category that matters. Mental health care deserves that same standard — especially when treatment-resistant depression has been the one domain where the best conventional options have consistently fallen short. Spravato is the FDA-approved, globally validated path forward for exactly that clinical situation, backed by over a decade of research and administered by a team that has the credentials and the culture to do it well.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll discuss your history honestly, answer every question, and give you a clear picture of whether Spravato makes sense for your situation. No charge, no pressure, complete confidentiality.
Our Heights location is easily accessible from Memorial via I-10. Three Houston locations serve Memorial patients, all open 5am to 9pm, seven days a week. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.